Shares of telehealth companies WeightWatchers and HIMS & Hers Health rose 5.4% and 10.2%, respectively. The US Food and Drug Administration said on Friday it will reconsider its decision to ban drug synthesizers from selling homemade versions of Eli Lilly's popular diet pills and diabetes pills. In response to a lawsuit filed by an industry group, the FDA said it would allow pharmaceutical companies to continue providing these drugs while reviewing whether tesipatide is in short supply.

Shares of telehealth companies WeightWatchers and HIMS & Hers Health rose 5.4% and 10.2%, respectively. The US Food and Drug Administration said on Friday it will reconsider its decision to ban drug synthesizers from selling homemade versions of Eli Lilly's popular diet pills and diabetes pills. In response to a lawsuit filed by an industry group, the FDA said it would allow pharmaceutical companies to continue providing these drugs while reviewing whether tesipatide is in short supply.